Blazing Star Merger Sub completes Walgreens debt tender offer
RICHMOND, VA - Indivior PLC (LON:INDV), a pharmaceutical company specializing in the treatment of substance use disorders, has announced the appointment of Joseph Ciaffoni as its new Chief Executive Officer, effective upon shareholder approval of a new remuneration policy at the company’s Annual General Meeting (AGM) scheduled for May 2025.
Ciaffoni, 53, who has been serving as an Independent (LON:IOG) Non-Executive Director on Indivior’s Board since December 2024, brings over three decades of experience in the pharmaceutical and biotech sectors to his new role. His career includes key leadership positions, most recently as President and CEO of Collegium Pharmaceutical (NASDAQ:COLL), and senior roles at Endo International (OTC:ENDPQ), Biogen (NASDAQ:BIIB), and Shionogi Inc.
The current CEO, Mark Crossley, will step down from his position and as a Board Director after a notable period at the helm. Crossley will support the transition process until the AGM, to ensure stability and continuity for the business.
David Wheadon, Chair of Indivior’s Board of Directors, expressed confidence in Ciaffoni’s appointment, highlighting his successful track record and the board’s anticipation of his contribution to the company’s growth. Ciaffoni himself expressed honor at the appointment and eagerness to drive Indivior’s future growth, emphasizing the company’s critical role in addiction treatment.
Under Crossley’s leadership since June 2020, Indivior has focused on expanding patient access to treatment and advancing its mission. Wheadon commended Crossley for his dedication and impact on the company and its commitment to patients.
The announcement, based on a press release statement, comes as Indivior continues to address substance use disorders globally, with a portfolio of treatments and product candidates that aim to transform the condition into a recognized and treated chronic disease.
Indivior’s commitment to combating substance use disorders is reflected in its global reach, with products available in over 30 countries and a workforce of over 1,000 individuals. The company is headquartered in Richmond, VA.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.